PPBT Valuation

Purple Biotech Ltd

Add to Watchlist

Advanced Chart

2.330

-0.29(-11.069%)1D

Overview
Forecast
Valuation
Earnings

PPBT Relative Valuation

PPBT's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PPBT is overvalued; if below, it's undervalued.

Historical Valuation

Purple Biotech Ltd (PPBT) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -6.44. The fair price of Purple Biotech Ltd (PPBT) is between NaN to NaN according to relative valuation methord.

Relative Value

Fair Zone

NaN-NaN

Current Price：2.33

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

37.57

P/B

Median3y

93.97

Median5y

141.14

-150.95

FCF Yield

Median3y

-111.32

Median5y

-72.50

Competitors Valuation Multiple

The average P/S ratio for PPBT's competitors is 4.15, providing a benchmark for relative valuation. Purple Biotech Ltd Corp (PPBT) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap